ArticleFrontiers in oncology2026
Association between preoperative neutrophil percentage-to-albumin ratio and survival outcomes in patients with colorectal cancer undergoing radical surgery: a retrospective study with external validation.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Accurate preoperative risk stratification remains a major clinical challenge in patients with colorectal cancer (CRC) undergoing radical surgery. Simple and readily available biomarkers that reflect systemic inflammation and nutritional status may improve prognostic assessment in routine clinical practice. Methods: This retrospective study included 581 patients with CRC who underwent radical surgery as the training cohort. Overall survival (OS) and disease-free survival (DFS) were the primary endpoints. NPAR was analyzed primarily as a continuous variable standardized per 1-SD increase. A pre-specified final model including NPAR, age, sex, tumor site, pathological stage, and log10-transformed CEA was used consistently across Cox regression, nomogram development, time-dependent ROC analysis, calibration, decision-curve analysis, and external validation. Dichotomized NPAR was retained only for descriptive and supplementary analyses. External validation was performed in 483 patients from an external clinical database. Results: In the training cohort, higher preoperative NPAR was associated with adverse clinicopathological features. After adjustment for age, sex, tumor site, pathological stage, and log10-transformed CEA, each 1-SD increase in NPAR was associated with shorter OS (HR 2.19, 95% CI 1.90-2.53, Conclusion: Preoperative NPAR showed an adjusted association with OS and DFS, and the direction of this association was reproduced in the external cohort. However, its incremental predictive value beyond conventional clinicopathological factors was limited, particularly for OS. NPAR may be considered a simple adjunctive marker of inflammatory and nutritional status, but its clinical utility for individualized risk prediction requires further validation in larger prospective cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.